The 2-Minute Rule for Journal of Allergy and Clinical Immunology
LTRAs will also be employed as add-on therapy if asthma is uncontrolled Regardless of the utilization of low-to-reasonable ICS doses.As mentioned before, LABA monotherapy just isn't suggested in people with asthma as it doesn't impact airway inflammation which is related to a heightened hazard of morbidity and mortality. LABAs are only proposed whe